SYNOPSYS INC quarterly report, Q3 FY2015

Synopsys, Inc. — Q3 FY2015 Form 10-Q

Reporting period: Fiscal quarter ended July 31, 2015; nine-month comparison is for the periods ended July 31, 2015 and 2014. Synopsys provides electronic design automation (EDA) software, intellectual property, hardware, and related services. More than 90% of revenue is generally time-based, with recognition commonly spread over multiyear contracts.

Financial performance

Unless noted otherwise, amounts are in millions of dollars. Comparisons are with the same period of fiscal 2014.

MetricQ3 FY2015Q3 FY2014Nine months FY2015Nine months FY2014
Revenue$555.8$521.8$1,655.1$1,518.5
Gross margin$426.3; 76.7%$406.3; 77.9%$1,276.0; 77.1%$1,183.0; 77.9%
Operating income$61.5$67.2$208.9$191.2
Operating margin11.1%12.9%12.6%12.6%
Net income$55.4$65.7$176.2$196.7
Diluted EPS$0.35$0.42$1.12$1.25
Operating cash flowNot provided for quarterNot provided for quarter$342.7$378.0
  • Q3 revenue grew 7%; management attributed growth to organic performance and prior-year acquisitions. Upfront license revenue increased 55% to $48.9 million, primarily reflecting higher hardware sales. Time-based license revenue rose 3% to $445.8 million; maintenance and service revenue rose 4% to $61.1 million.
  • Q3 total cost of revenue and operating expenses increased 9% to $494.3 million, outpacing revenue growth. Management cited higher headcount and acquisition-related costs, as well as the timing of expenses. Net income declined 16% year over year.
  • For the first nine months, revenue increased 9%, while net income fell 10%. The effective tax rate was 21.9%, versus 6.4% in the prior-year period; the filing attributes the difference chiefly to acquired-technology integration and prior-year tax settlements and benefits.
  • At July 31, cash and cash equivalents were $986.4 million and short-term investments were $136.5 million, totaling $1,122.9 million. Working capital was $168.2 million, compared with $117.9 million at October 31, 2014. Deferred revenue totaled $1,003.3 million, including current and long-term amounts.
  • Total debt was $212.5 million: $160.0 million drawn on the revolving facility and $52.5 million under the term loan. Nine-month cash used for investing was $333.7 million, including $137.2 million net purchases of short-term investments and $126.9 million for acquisitions and intangible assets; financing provided $13.4 million.

Material changes and notable items

  • Revenue mix shifted modestly toward upfront licenses: these were 9% of Q3 revenue versus 6% a year earlier, while time-based licenses were 80% versus 83%.
  • Q3 gross margin declined by about 1.2 percentage points year over year, and operating margin declined by about 1.8 points, reflecting faster expense growth than revenue.
  • Operating cash flow for the first nine months declined $35.3 million year over year, which management primarily attributed to higher vendor payments and lower net income.
  • The company completed several acquisitions for aggregate consideration of $120.8 million, net of acquired cash, funded with existing cash. Preliminary allocation included $92.2 million of goodwill and $37.1 million of identifiable intangible assets; estimates remained subject to finalization.
  • During the nine-month period, Synopsys repurchased $180.0 million of shares under an accelerated repurchase agreement, purchasing approximately 4.0 million shares at an average $45.37 per share. About $200.3 million remained authorized for repurchases.
  • A November 2014 restructuring program cost $15.1 million and was substantially completed, with no balance outstanding at July 31.

Outlook, risks, and contingencies

  • Management described the business outlook as solid, citing technology leadership, customer relationships, the time-based revenue model, expense management, and acquisitions. It expects time-based revenue to remain approximately 90% of total revenue. The filing provides no specific numerical earnings or revenue guidance.
  • Management said available cash, short-term investments, operating cash generation, and revolving credit availability should meet routine business needs for at least the next twelve months. Approximately $777 million of cash, cash equivalents, and short-term investments was held by foreign subsidiaries and considered indefinitely reinvested; repatriation could trigger additional U.S. taxes.
  • The revolving credit facility was increased from $350 million to $500 million and extended to May 2020. Borrowings are floating-rate; the filing reports July 31 rates of LIBOR plus 1.000% on the revolver and LIBOR plus 1.125% on the term loan. The company must comply with leverage and interest-coverage covenants.
  • In Mentor Graphics patent litigation, a jury assessed approximately $36 million in damages and the court enjoined certain sales activities involving features found to infringe. Synopsys released revised ZeBu software and appealed; Mentor also appealed. The filing does not state that the judgment was a recorded loss accrual.
  • Tax exposures include $115.0 million of gross unrecognized tax benefits, exclusive of interest and penalties. The company said resolution of certain audits or statute expirations could reduce unrecognized tax benefits by $0–$23 million within twelve months, but timing and settlement amounts were uncertain. It recorded tax benefits from IRS and Taiwan settlements during the period.
  • Key risks include semiconductor-market and customer spending weakness or consolidation; acquisition integration and execution; competition and product development; revenue timing and customer concentration; foreign currency exposure; tax outcomes; cybersecurity and product defects; and intellectual-property litigation. The company also noted uncertainty over the potential tax implications of a Tax Court opinion concerning stock-based compensation in intercompany cost-sharing arrangements.

Important facts for investors to verify

  • Whether revenue growth and the increased upfront-license contribution persist, given the variability of hardware sales and contract timing.
  • Whether operating expenses, especially research and development and acquisition-related costs, moderate enough to stabilize or improve margins and earnings.
  • Cash conversion, debt levels, revolving-facility utilization, covenant headroom, and the availability and tax cost of foreign-held funds.
  • Developments in the Mentor litigation, including appeals, injunction scope, and any resulting financial or operating effects.
  • Final acquisition purchase-price allocations, integration outcomes, and any effect of tax audits or changes in tax guidance on the effective tax rate.